Back
Viking Therapeutics Stock Price Chart
Sponsored
VKTX
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
45
VKTX
Viking Therapeutics
Last Price:
64.63
Seasonality Move:
38.04%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 71.35 | Sell |
20-day SMA: | 67.56 | Sell |
50-day SMA: | 64.43 | Buy |
200-day SMA: | 60.03 | Buy |
8-day EMA: | 68.57 | Sell |
20-day EMA: | 67.8 | Sell |
50-day EMA: | 65.05 | Sell |
200-day EMA: | 55.42 | Buy |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.41 | Buy |
Relative Strength Index (14 RSI): | 46.54 | Sell |
Chaikin Money Flow: | -1563854 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.12 - 71.48) | Sell |
Bollinger Bands (100): | (53.04 - 66.68) | Buy |
Viking Therapeutics Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 64.63 while VKTX 8-day simple moving average is 71.35, which is a Sell signal.
- The stock price of VKTX is 64.63 while Viking Therapeutics 20-day SMA is 67.56, which makes it a Sell.
- Viking Therapeutics 50-day simple moving average is 64.43 while VKTX share price is 64.63, making it a Buy technically.
- VKTX stock price is 64.63 and Viking Therapeutics 200-day simple moving average is 60.03, creating a Buy signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a Sell
The current Viking Therapeutics [VKTX] share price is $64.63. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
7.2B
Price in USD:
64.63
Share Volume:
8.43M
Viking Therapeutics 52-Week Range
52-Week High:
99.41
52-Week Low:
9.34
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?
The Viking Therapeutics stock price is 64.63 USD today. -
Will VKTX stock go up or go down?
Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viking Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 64.63 while VKTX 8-day exponential moving average is 68.57, which is a Sell signal.
- The stock price of VKTX is 64.63 while Viking Therapeutics 20-day EMA is 67.80, which makes it a Sell.
- Viking Therapeutics 50-day exponential moving average is 65.05 while VKTX share price is 64.63, making it a Sell technically.
- VKTX stock price is 64.63 and Viking Therapeutics 200-day simple moving average is 55.42, creating a Buy signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
- VKTX Moving Average Covergence Divergence (MACD) indicator is 1.41, suggesting Viking Therapeutics is a Buy
- Viking Therapeutics Relative Strength Index (RSI) is 46.54, which suggest Viking Therapeutics is oversold
- The Bollinger Bands (25) for Viking Therapeutics is (62.12 - 71.48), which suggest Viking Therapeutics is a Buy
- The Bollinger Bands (100) for Viking Therapeutics is (53.04 - 66.68), which suggest Viking Therapeutics is a Buy
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.